Alternatives to estrogen replacement therapy

Annals of the New York Academy of Sciences

Volumn 900, Issue , 2000, Pages 413-415

  Maroulis, George B ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; RALOXIFENE; TAMOXIFEN; TIBOLONE;

CONFERENCE PAPER; ESTROGEN THERAPY; FEMALE; HUMAN;

EID: 0034071138     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06254.x     Document Type: Conference Paper

References (9)

1. 1. KUIPER, G.G., B. CARLSSON, K. GRANDIEN et al. 1998. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138: 863-870.
2. 2. SHUGHRUE, P.F., M.V. LANE & I. MERCHENTHALER. 1997. Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system. J. Comp. Neurol. 388: 507-525.
3. 3. MCDONNELL, D.P., D.L. CLEMM, T. HERMANN et al. 1995. Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Molec. Endocrinol. 9: 659-669.
4. 4. MCDONNELL, D.P. & B.L. WAGNER. 1998. The mechanism of action of estrogen and progesterone. In Estrogens and Progesterogens in Clinical Practice. I. Fraser, R. Jansen, R.A. Lobo & M. Whitehead, Eds. Churchill-Livingstone. London.
5. 5. RALOXIFENE (package insert). International Multicenter Study. 1998. Eli Lilly & Co. Indianapolis.
6. 6. LOBO, R.A. 1998. Designer estrogens: clinical aspects. In Fertility and Reproductive Medicine. R.D. Kempers, J. Cohen, A.F. Haney & J.B. Younger, Eds.: 555-562. Elsevier. New York.
7. 7. ANTHONY, M.S., T.B. CLARKSON, C.L. HUGHES, JR. et al. 1996. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkey. J. Nutr. 126: 43-50.
8. 8. RYMER, J.M. 1998. The effects of tibolone. Gynecol. Endocrinol. 12: 213-220.
9. 9. RYMER, J., M.G. CHAPMAN & I. FOGELMAN. 1994. Effect of tibolone on postmenopausal bone loss. Osteoporosis Int. 4: 314-317.